Literature DB >> 21158323

Possible devices to temporary cover the open abdomen: pros and cons.

K J P van Wessem1.   

Abstract

In the last 25 years increased popularity of damage control surgery and recognition of abdominal compartment syndrome has lead to a raised incidence of open abdomens. Even though these procedures are often life-saving, morbidity and mortality associated with an open abdomen remains high. Third spacing after aggressive fluid resuscitation, fascial retraction, ventilatory problems and fistula formations are problems often associated with an open abdomen. Management of an open abdomen is often complicated and challenging. The viscera need to be protected and the abdomen needs coverage. Several techniques have been described for both temporary and definitive closure. This article will discuss the pros and cons of several available temporary devices to cover the abdomen and literature will be reviewed.

Entities:  

Mesh:

Year:  2010        PMID: 21158323

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  3 in total

Review 1.  Open abdomen management: a review of its history and a proposed management algorithm.

Authors:  Barbara E Kreis; Alexander Jc de Mol van Otterloo; Robert W Kreis
Journal:  Med Sci Monit       Date:  2013-07-03

2.  Outcome of trauma-related emergency laparotomies, in an era of far-reaching specialization.

Authors:  Falco Hietbrink; Diederik Smeeing; Steffi Karhof; Henk Formijne Jonkers; Marijn Houwert; Karlijn van Wessem; Rogier Simmermacher; Geertje Govaert; Miriam de Jong; Ivar de Bruin; Luke Leenen
Journal:  World J Emerg Surg       Date:  2019-08-14       Impact factor: 5.469

3.  Underlying disease determines the risk of an open abdomen treatment, final closure, however, is determined by the surgical abdominal history.

Authors:  Steffi Karhof; Mark Haverkort; Rogier Simmermacher; Falco Hietbrink; Luke Leenen; Karlijn van Wessem
Journal:  Eur J Trauma Emerg Surg       Date:  2019-08-26       Impact factor: 3.693

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.